These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 34756952

  • 1. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 3. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC.
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [Abstract] [Full Text] [Related]

  • 4. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
    Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L.
    J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
    [Abstract] [Full Text] [Related]

  • 5. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
    Cambier A, Dossier C, Hogan J, Baudouin V, Maisin A, Couderc A, Kwon T, Gleeson PJ, Monteiro RC.
    Pediatr Nephrol; 2022 Jul; 37(7):1597-1603. PubMed ID: 34997322
    [Abstract] [Full Text] [Related]

  • 6. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC.
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [Abstract] [Full Text] [Related]

  • 7. Murine Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y.
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [Abstract] [Full Text] [Related]

  • 8. Molecular Insights into the Pathogenesis of IgA Nephropathy.
    Robert T, Berthelot L, Cambier A, Rondeau E, Monteiro RC.
    Trends Mol Med; 2015 Dec; 21(12):762-775. PubMed ID: 26614735
    [Abstract] [Full Text] [Related]

  • 9. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 May 01; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 11. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
    Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC.
    J Exp Med; 2000 Jun 05; 191(11):1999-2009. PubMed ID: 10839814
    [Abstract] [Full Text] [Related]

  • 12. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
    Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogné M, Moura IC, Monteiro RC.
    J Exp Med; 2012 Apr 09; 209(4):793-806. PubMed ID: 22451718
    [Abstract] [Full Text] [Related]

  • 13. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Apr 09; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 14. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 09; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 15. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
    Xu L, Li B, Huang M, Xie K, Li D, Li Y, Gu H, Fang J.
    PLoS One; 2016 Oct 09; 11(7):e0159426. PubMed ID: 27437939
    [Abstract] [Full Text] [Related]

  • 16. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 17. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb 29; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 18. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 19. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
    Xie X, Liu P, Gao L, Zhang X, Lan P, Bijol V, Lv J, Zhang H, Jin J.
    J Pathol; 2021 Jun 11; 254(2):159-172. PubMed ID: 33660264
    [Abstract] [Full Text] [Related]

  • 20. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 11; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.